Dolby Laboratories (NYSE:DLB) Issues FY25 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) updated its FY25 earnings guidance on Tuesday. The company provided EPS guidance of $2.43-2.58 for the period, compared to the consensus EPS estimate of $2.77. The company issued revenue guidance of $1.33-1.39 billion, compared to the consensus revenue estimate of $1.33 billion. Dolby Laboratories also updated its Q1 guidance to $0.53-0.68 EPS.

Dolby Laboratories Stock Down 0.6 %

Shares of DLB stock traded down $0.44 during mid-day trading on Tuesday, hitting $70.91. 385,415 shares of the stock were exchanged, compared to its average volume of 396,072. Dolby Laboratories has a 52-week low of $66.35 and a 52-week high of $90.06. The firm has a fifty day moving average of $73.66 and a 200 day moving average of $76.09. The company has a market cap of $6.76 billion, a PE ratio of 32.38 and a beta of 0.98.

Dolby Laboratories declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, August 7th that authorizes the company to repurchase $350.00 million in shares. This repurchase authorization authorizes the electronics maker to buy up to 5% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

DLB has been the subject of a number of recent analyst reports. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a report on Monday. Barrington Research reissued an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Friday, September 20th.

View Our Latest Report on DLB

Insider Activity

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the transaction, the chief executive officer now owns 83,721 shares in the company, valued at approximately $6,205,400.52. The trade was a 25.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 39.54% of the company’s stock.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.